神经周围与静脉地塞米松作为外周神经阻滞佐剂的系统综述与荟萃分析
结果显示神经周围地塞米松使镇痛时长延长3.77小时(95%CI 1.87-5.68,P<0.001),并延长运动与感觉阻滞时长,24小时口服阿片类药物消耗略少,未发现不良事件增加。
要点
- 神经周围地塞米松较静脉给药延长镇痛时长3.77小时(95%CI 1.87-5.68,P<0.001)。
- 神经周围地塞米松延长运动阻滞3.47小时、感觉阻滞2.28小时。
- 24小时口服阿片消耗略少(7.1mg口服吗啡当量,95%CI 0.74-13.5,P=0.029),不良事件未增加。
核心结论
- 神经周围地塞米松在纳入的随机对照试验中延长了镇痛时长,但3.77小时的效应幅度提示需权衡是否常规使用或仅用于特定患者。
主要发现
- 神经周围地塞米松较静脉地塞米松延长镇痛时长3.77小时(95%CI 1.87-5.68,P<0.001),统计异质性高。
- 神经周围地塞米松延长运动阻滞3.47小时(95%CI 1.49-5.45,P<0.001)和感觉阻滞2.28小时(95%CI 0.38-4.17,P=0.019)。
- 神经周围地塞米松组24小时口服阿片消耗略少(7.1mg口服吗啡当量,95%CI 0.74-13.5mg,P=0.029)。
- 其他次要结局无统计学显著差异,未检测到不良事件增加。
临床怎么用
- 神经周围地塞米松可延长外周神经阻滞镇痛时长,但需考虑其超说明书使用性质及效应幅度是否具有临床重要性。
局限性
- 纳入研究存在高统计异质性,可能影响合并效应量的解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Dexamethasone is a useful adjuvant in regional anesthesia that is used to prolong the duration of analgesia for peripheral nerve blocks. Recent randomized controlled trials (RCTs) have demonstrated conflicting results as to whether perineural versus intravenous (IV) administration is superior in this regard, and the perineural use of dexamethasone remains off-label. Therefore, we sought to perform a systematic review and meta-analysis of RCTs. METHODS: In accordance with PRISMA guidelines, we performed a random-effects meta-analysis of RCTs comparing perineural versus IV dexamethasone with duration of analgesia as the primary outcome. RESULTS: Eleven RCTs met the inclusion criteria with a total of 1076 subjects. Perineural dexamethasone prolonged the duration of analgesia by 3.77 hours (95% confidence interval [CI], 1.87-5.68 hours; P < 0.001) compared to IV dexamethasone, with high statistical heterogeneity. For secondary outcomes, perineural dexamethasone prolonged the duration of both motor (3.47 hours [95% CI, 1.49-5.45]; P < 0.001) and sensory (2.28 hours [95% CI, 0.38-4.17]; P = 0.019) block compared to IV administration. Furthermore, perineural dexamethasone patients consumed slightly less oral opioids at 24 hours than IV dexamethasone patients (7.1 mg of oral morphine equivalents [95% CI, 0.74-13.5 mg]; P = 0.029), and there were no statistically significant differences in the other secondary outcomes. Notably, no increase in adverse events was detected. CONCLUSIONS: Perineural dexamethasone prolongs the duration of analgesia across the RCTs included in our meta-analysis. The magnitude of effect of 3.77 hours raises the question as to whether perineural dexamethasone should be administered routinely over its IV counterpart-or reserved for selected patients where such prolongation would be clinically important.
引用
- Chong MA, Berbenetz NM, Lin C, et al. Perineural Versus Intravenous Dexamethasone as an Adjuvant for Peripheral Nerve Blocks: A Systematic Review and Meta-Analysis. Reg Anesth Pain Med. 2017. PMID: 28252523. doi:10.1097/AAP.0000000000000571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。